Podcasts

In this podcast, Jonathan Stine, MD, from the the Milton S. Hershey Medical Center of Pennsylvania State University, discusses his proof-of-concept study on the effects of exercise on gut dysbiosis and fatty liver disease.
He discusses the American Journal of Gastroenterology's recent publication of a review of major advancements in gastroenterology over the previous decade.
He talks about his session at our Advances in Inflammatory Bowel Disease regional meeting in Los Angeles, during which he will speak about the importance of dysplasia surveillance and how dysplasia should be tracked in the future.
In this podcast, Christina Y. Ha, MD, provides insight into the prevention and management of Clostridioides difficile infection among patients with inflammatory bowel disease. It is a topic she will be discussing at the upcoming virtual Advances in Inflammatory Bowel Diseases Regional Meeting.
He discusses research into the prevalence of gastroesophageal reflux disease and proton pump inhibitor-refractory GERD.
In this 12-minute podcast, Vrinda Bhardwaj, MD, from Children's Hospital Los Angeles, reviews the use of elemental and elimination diets for treatment of eosinophilic gastrointestinal diseases in children.
He discusses his session on endocrine pathways and therapeutic options for patients with nonalcoholic fatty liver disease, which he presented at Harvard University’s 21st Annual Symposium on NAFLD.
She discusses her research on assays for measuring drug concentrations and anti-drug antibodies, as well as algorithmic approaches to proactive therapeutic drug monitoring and how they help patients with IBD achieve and maintain remission.
In this podcast, Parambir Dulai, MD, discusses his recent research on treating inflammatory bowel disease to achieve endoscopic remission, through the use of a treat-to-target approach using algorithmic treatment adjustments.
He discusses how gastroenterologists can resume semi-elective and elective endoscopies by following key guidelines to protect patients and staff against COVID-19.